dr. amengual on dual targeting with an hdac 6 inhibitor and bortezomib in lymphoma
Published 10 years ago • 236 plays • Length 1:50Download video MP4
Download video MP3
Similar videos
-
2:16
dr. amengual on novel therapeutics for b-cell lymphoma
-
10:09
understanding diffuse large b-cell lymphoma with jennifer amengual, md
-
1:01
ask unmc: lymphoma treatments
-
2:55
everolimus and itacitinib in patients with hl r/r to brentuximab vedotin and checkpoint inhibitors
-
3:11
cd47-targeting antibody: targeting the source of non-hodgkin lymphoma
-
1:39
dr. pagel on determining treatment based on genetic risk in double- and triple-hit lymphoma
-
39:33
aviptadil
-
2:19
session highlights: autosct in t-cell lymphoma, classification updates and fertility preservation
-
1:09
areas of unmet need for dlbcl: primary refractory disease and double-hit lymphoma
-
3:27
double hit lymphoma: a challenge for lymphoma experts
-
2:10
dial me in: dual immunodulation in aggressive lymphoma
-
1:21
the future of lymphoma treatment – combining new therapies with molecular diagnosis
-
1:31
evaluating myc, bcl2 and bcl6 expression to define double-expressor lymphoma
-
1:18
advances in immunotherapy for lymphoma
-
2:00
lymphoma
-
2:11
meet jeremy abramson, md, lymphoma physician | mass general brigham
-
8:18
mrd & me
-
2:08
cellular and targeted therapies for hodgkin lymphoma
-
0:56
dr. younes discusses abvd versus a avd as front-line treatment in hodgkin lymphoma